Generative AI In Life Sciences Market Boosts Personalized Medicine
According to Shivani Zoting, who specializes in healthcare and life sciences market intelligence with 5+ years of experience in market research and industry analysis, the generative AI in life sciences market shows strong growth driven by rising demand for personalized medicine, faster drug discovery, and AI-enabled clinical trial optimization. Her analysis highlights key segments such as novel molecule generation, protein design, and drug discovery applications, with North America leading the market and Asia Pacific emerging as the fastest-growing region. She also identifies a competitive landscape dominated by companies like NVIDIA, Microsoft, Alphabet (Google DeepMind), IBM, and IQVIA, alongside specialized players advancing AI-driven life sciences innovation.
Last Updated : 21 April 2026
Category: Healthcare IT
Insight Code: 5735
Format: PDF / PPT / Excel